Medications for Small Cell Lung Carcinoma
9 results
Cosela (trilaciclib)
(trilaciclib)PTC Therapeutics Inc
Usage: COSELA is indicated to reduce the incidence of chemotherapy-induced myelosuppression in adults when given before a platinum/etoposide or topotecan regimen for extensive-stage small cell lung cancer (ES-SCLC).
Etoposide (etoposide)
(Etoposide)Hikma Pharmaceuticals USA Inc.
Usage: Etoposide Injection, USP is indicated for managing refractory testicular tumors in combination with other chemotherapeutic agents, and as a first-line treatment for small cell lung cancer, also in combination with other approved therapies.
Hycamtin (topotecan)
(topotecan)Sandoz Inc
Usage: HYCAMTIN® capsules are indicated for treating relapsed small cell lung cancer (SCLC) in patients who have had a prior complete or partial response and are at least 45 days post first-line chemotherapy.
Imdelltra (amg757) (tarlatamab-dlle)
(Tarlatamab-dlle)Amgen Inc
Usage: IMDELLTRA is indicated for adults with extensive stage small cell lung cancer (ES-SCLC) that has progressed after platinum-based chemotherapy. This approval is accelerated and depends on the verification of clinical benefit in future trials.
Imfinzi (durvalumab)
(Durvalumab)AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for treating various cancers in adults, including non-small cell lung cancer (both resectable and unresectable), small cell lung cancer (limited and extensive stage), biliary tract cancers, unresectable hepatocellular carcinoma, mismatch repair deficient endometrial cancer, and muscle invasive bladder cancer, often in combination with other therapies.
Tecentriq (atezolizumab)
(atezolizumab)Genentech, Inc.
Usage: TECENTRIQ is indicated for treating various cancers, including stage II to IIIA non-small cell lung cancer (NSCLC), extensive-stage small cell lung cancer, unresectable hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and unresectable alveolar soft part sarcoma. It is used alone or in combination with other therapies.
Topotecan hydrochloride (topotecan hydrochloride)
(TOPOTECAN HYDROCHLORIDE)Fresenius Kabi USA, LLC
Usage: Topotecan hydrochloride is indicated for the treatment of metastatic ovarian cancer after chemotherapy progression, small cell lung cancer in platinum-sensitive patients post-first-line treatment, and, in combination with cisplatin, for Stage IV-B or recurrent cervical cancer not suitable for curative treatment.
Topotecan hydrochloride (topotecan hydrochloride )
(Topotecan Hydrochloride)Bedford Laboratories
Usage: Topotecan hydrochloride is indicated for treating small cell lung cancer that is sensitive after first-line chemotherapy failure, and in combination with cisplatin for stage IV-B, recurrent, or persistent cervical carcinoma unresponsive to curative surgery or radiation.
Zepzelca (lurbinectedin)
(Lurbinectedin)Jazz Pharmaceuticals, Inc.
Usage: ZEPZELCA is indicated for treating adult patients with metastatic small cell lung cancer (SCLC) who have disease progression after platinum-based chemotherapy. This approval is under accelerated conditions, contingent on further confirmation of clinical benefit in ongoing trials.